Cargando…

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Ju, Hye-Lim, Ro, Simon Weonsang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949285/ https://www.ncbi.nlm.nih.gov/pubmed/27478325 http://dx.doi.org/10.21147/j.issn.1000-9604.2016.03.14

Ejemplares similares

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023)

Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

CD147/Basigin: a Warburg oncogene in hepatocellular carcinoma?
por: Calvisi, Diego Francesco
Publicado: (2016)

Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
por: Geng, Jie-Jie, et al.
Publicado: (2017)

Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
por: Chung, Sook In, et al.
Publicado: (2016)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma
por: Wang, Shi-Jie, et al.
Publicado: (2020)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
por: Park, Hyunjung, et al.
Publicado: (2022)

Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
por: Park, Hyunjung, et al.
Publicado: (2023)

CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
por: Kendrick, Agnieszka A., et al.
Publicado: (2016)

Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma
por: Thakur, A., et al.
Publicado: (2020)

CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Peng, Fei, et al.
Publicado: (2017)

CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells
por: Ding, Pengfei, et al.
Publicado: (2017)

Sleeping Beauty transposon system harboring HRAS, c-Myc and shp53 induces sarcomatoid carcinomas in mouse skin
por: JUNG, SUNYOUNG, et al.
Publicado: (2013)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
por: Zhang, Ren-Yu, et al.
Publicado: (2019)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019)

The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147
por: Luo, Ling-Juan, et al.
Publicado: (2017)

CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma
por: Chen, Ruo, et al.
Publicado: (2016)

Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
por: Lu, Meng, et al.
Publicado: (2018)

A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
por: Fu, Zhi-guang, et al.
Publicado: (2016)

Translating Metabolic Reprogramming into New Targets for Kidney Cancer
por: Abu Aboud, Omran, et al.
Publicado: (2017)

Chlamydia Anti-apoptosis – A By-product of Metabolic Reprogramming?
por: Sixt, Barbara Susanne, et al.
Publicado: (2017)

Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
por: Han, Sojung, et al.
Publicado: (2022)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
por: Wang, Qingqing, et al.
Publicado: (2022)

Reprogrammed lipid metabolism protects inner nuclear membrane against unsaturated fat
por: Romanauska, Anete, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
por: Soukupova, Jitka, et al.
Publicado: (2021)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma
por: Xu, Yun-Ji, et al.
Publicado: (2023)

Rewired lipid metabolism as an actionable vulnerability of aggressive colorectal carcinoma
por: Capece, Daria, et al.
Publicado: (2022)

Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
por: Pinheiro, Céline, et al.
Publicado: (2009)

CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma
por: Nasry, Walaa Hamed Shaker, et al.
Publicado: (2018)

Lipid metabolic reprogramming of hepatic CD4(+) T cells during SIV infection
por: Clain, Julien A., et al.
Publicado: (2023)

Lipids link immune suppression to effective immunotherapy in steatotic hepatocellular carcinoma
por: Li, Bing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ogn4acq1toulc89bmmdpefr63k